il-12 dna
Vaccineexperimental
Clinical trial activity
8 trials · 16 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2004 (NCT00323206)
Timeline
Indications
Mechanism of action
- Interleukin-12 subunit betaSupplementation
IL12B supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- il-12 dna
- il-12p dna
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05781542 | Phase 1 | Apr 10, 2023 | Access to Advanced Health Institute (AAHI), Department of Health and Human Services, HIV Vaccine Trials Network, Inovio Pharmaceuticals, National Institute of Allergy and Infectious Diseases (NIAID), The Wistar Institute |
| NCT04095689 | Phase 2 | Jan 31, 2020 | Merck, Methodist Cancer Center, Houston, Texas |
| NCT01859325 | Phase 1 | May 10, 2013 | National Institute of Allergy and Infectious Diseases (NIAID), Profectus BioSciences, Inc. |
| NCT01578889 | Phase 1 | May 1, 2012 | National Institute of Allergy and Infectious Diseases (NIAID), University of Rochester |
| NCT00195312 | Phase 1 | Aug 1, 2005 | Pfizer, Wyeth |
| NCT00115960 | Phase 1 | Jun 26, 2005 | Harvard University, National Institute of Allergy and Infectious Diseases (NIAID), University of Rochester |
| NCT00111605 | Phase 1 | May 23, 2005 | National Institute of Allergy and Infectious Diseases (NIAID), University of Alabama, Birmingham, Vanderbilt University |
| NCT00323206 | N/A | Jun 1, 2004 | University of South Florida |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (16)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 5 | 5 | 1 | 2005 |
| University of Rochester | Academic/Hospital | 2 | 0 | 1 | 2005 |
| Access to Advanced Health Institute (AAHI) | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Department of Health and Human Services | Government | 1 | 0 | 1 | 2023 |
| Harvard University | Academic/Hospital | 1 | 0 | 1 | 2005 |
| HIV Vaccine Trials Network | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Inovio Pharmaceuticals | For profit | 1 | 0 | 1 | 2023 |
| Merck | For profit | 1 | 0 | 1 | 2020 |
| Methodist Cancer Center, Houston, Texas | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Pfizer | For profit | 1 | 1 | 1 | 2005 |
| Profectus BioSciences, Inc. | For profit | 1 | 0 | 1 | 2013 |
| The Wistar Institute | Academic/Hospital | 1 | 0 | 1 | 2023 |
| University of Alabama, Birmingham | Academic/Hospital | 1 | 0 | 1 | 2005 |
| University of South Florida | Academic/Hospital | 1 | 1 | 1 | 2004 |
| Vanderbilt University | Academic/Hospital | 1 | 0 | 1 | 2005 |
| Wyeth | For profit | 1 | 0 | 1 | 2005 |
16 organizations
Page 1 / 1